A phase i open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer

Robin L. Jones, Johanna C. Bendell, David C. Smith, Konstanze Diefenbach, John Lettieri, Oliver Boix, A. Craig Lockhart, Cindy O'Bryant, Kathleen N. Moore

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase i open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences